
- English
- ePUB (mobile friendly)
- Available on iOS & Android
About this book
In recent years, substantial efforts have been initiated to develop new drugs, vaccines, and other medical interventions against biological agents that could be used in bioterrorist attacks against civilian populations. According to a new congressionally mandated report from the Institute of Medicine and National Research Council of the National Academies, to successfully develop these drugs, vaccines, and other medical interventions against biowarfare agents, Congress should authorize the creation of a new agency within the Office of the Secretary of the U.S. Department of Defense. The committee recommended that Congress should improve liability protections for those who develop and manufacture these products, to stimulate willingness to invest in new research and development for biowarfare protection. Giving Full Measure to Countermeasures also identifies other challenges"e;such as the need for appropriate animal models and laboratories equipped with high-level biosafety protections"e;that will require attention if DoD efforts to develop new medical countermeasures are to be successful.
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- COVER PAGE
- THE NATIONAL ACADEMIES
- COMMITTEE ON ACCELERATING THE RESEARCH, DEVELOPMENT, AND ACQUISITION OF MEDICAL COUNTERMEASURES AGAINST BIOLOGICAL WARFARE AGENTS
- Reviewers
- Preface
- Contents
- Figures, Tables, and Boxes
- Abbreviations and Acronyms
- Executive Summary
- 1 Ending Half-Measures for Countermeasures: The Challenge and Major Recommendations
- 2 Organizing Research and Development for Medical Countermeasures to Accomplish Essential Functions
- 3 Challenges in the Research and Development of Medical Countermeasures Against Biological Warfare Agents
- APPENDIX A Background: The Current DoD Medical Biowarfare Countermeasures Program
- APPENDIX B Agendas for Information-Gathering Meetings
- APPENDIX C Acknowledgments
- APPENDIX D Biographical Sketches